|The ACTBL2 actbl2 (Catalog #MBS854880) is an Antibody produced from Rabbit and is intended for research purposes only. The product is available for immediate purchase. The ACTBL2 Antibody reacts with Human and may cross-react with other species as described in the data sheet. MyBioSource\'s ACTBL2 can be used in a range of immunoassay formats including, but not limited to, Western Blot (WB), Immunohistochemistry (IHC).
Peptide ELISA titer: 1:10,000-80,000
Western blot analysis: 1:500-1,000
Optimal dilutions/concentrations should be determined by the end user. Researchers should empirically determine the suitability of the ACTBL2 actbl2 for an application not listed in the data sheet. Researchers commonly develop new applications and it is an integral, important part of the investigative research process.
The ACTBL2 actbl2 product has the following accession number(s) (GI #393290851) (NCBI Accession #NP_001017992.1). Researchers may be interested in using Bioinformatics databases such as those available at The National Center for Biotechnology Information (NCBI) website for more information about accession numbers and the proteins they represent. Even researchers unfamiliar with bioinformatics databases will find the NCBI databases to be quite user friendly and useful.
To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
Please refer to the product datasheet for known applications of a given antibody. We\'ve tested the ACTBL2 Antibody with the following immunoassay(s):
Testing Data #2
Source Note: Rabbit polyclonal ACTBL2 (1) antibody was raised against a 16 amino acid peptide from intermediate residues of human ACTBL2 protein.
Reactivity Note: Not yet tested in other species. In general, we may offer more than one antibody to a given target to enable options for the researcher. Available antibodies recognizing ACTBL2 are readily searchable from our website. Different antibodies against the same target such as ACTBL2 may be optimized or tested for different applications and species. This enables researchers to select the option that may be best for their model system, to screen more than antibody to determine which one may be best for their model system, as well as to use more than one antibody to follow up on and validate their results.